EU regulatory news highlights February 2026

From the regulatory newsfeeds of the European Medicines Agency’s (EMA), the European Commission (EC) and the Heads of Medicine Agencies (HMA), Arex Advisor has rounded up a selection of highlights from the past month. EMA CHMP sets priorities in 2026 workplan 2 February 2026The Committee for Medicinal Products for Human Use (CHMP) has outlined its […]